These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6795061)

  • 21. No effect of factor Xa or tissue thromboplastin and factor VII on the activation of plasminogen.
    Wiman B; Holm T; Prydz H
    Thromb Res; 1976 Nov; 9(5):523-5. PubMed ID: 136768
    [No Abstract]   [Full Text] [Related]  

  • 22. Functional consequences of mutations in Ser-52 and Ser-60 in human blood coagulation factor VII.
    Iino M; Foster DC; Kisiel W
    Arch Biochem Biophys; 1998 Apr; 352(2):182-92. PubMed ID: 9587405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The coagulation factor VII in pregnancy.
    Dalaker K; Prydz H
    Br J Haematol; 1984 Feb; 56(2):233-41. PubMed ID: 6607066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation.
    Sørensen B; Johansen P; Christiansen K; Woelke M; Ingerslev J
    J Thromb Haemost; 2003 Mar; 1(3):551-8. PubMed ID: 12871465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG; Cohen BM; Cohen E
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnesium and manganese ions accelerate tissue factor-induced coagulation independently of factor IX.
    van den Besselaar AM
    Blood Coagul Fibrinolysis; 2002 Jan; 13(1):19-23. PubMed ID: 11994563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of the initiation of coagulation by factor VII.
    Nemerson Y
    Haemostasis; 1983; 13(3):150-5. PubMed ID: 6350119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractions.
    Sandset PM; Abildgaard U; Pettersen M
    Thromb Res; 1987 Aug; 47(4):389-400. PubMed ID: 3499007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor.
    Rao LV; Ruf W
    Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sphingosine inhibits monocyte tissue factor-initiated coagulation by altering factor VII binding.
    Conkling PR; Patton KL; Hannun YA; Greenberg CS; Weinberg JB
    J Biol Chem; 1989 Nov; 264(31):18440-4. PubMed ID: 2808383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part I.
    Shah PK; Kaul S; Nilsson J; Cercek B
    Circulation; 2001 Nov; 104(19):2376-83. PubMed ID: 11696481
    [No Abstract]   [Full Text] [Related]  

  • 32. Activation of bovine factor IX by the reaction product of bovine factor VII and human tissue factor.
    Liu DY; Rosen S
    Chin Med J (Engl); 1994 Mar; 107(3):181-5. PubMed ID: 8088177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dimerization of tissue factor supports solution-phase autoactivation of factor VII without influencing proteolytic activation of factor X.
    Doñate F; Kelly CR; Ruf W; Edgington TS
    Biochemistry; 2000 Sep; 39(37):11467-76. PubMed ID: 10985793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between coagulation factors VII and X with triglyceride rich lipoproteins.
    de Sousa JC; Soria C; Ayrault-Jarrier M; Pastier D; Bruckert E; Amiral J; Bereziat G; Caen JP
    J Clin Pathol; 1988 Sep; 41(9):940-4. PubMed ID: 3056986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TISSUE EXTRACTS AND THEIR SENSITIVITY TO FACTOR VII AND FACTOR X.
    DENSON KW
    Thromb Diath Haemorrh; 1964 Apr; 11():146-54. PubMed ID: 14171582
    [No Abstract]   [Full Text] [Related]  

  • 36. Regulation of coagulation by a multivalent Kunitz-type inhibitor.
    Broze GJ; Girard TJ; Novotny WF
    Biochemistry; 1990 Aug; 29(33):7539-46. PubMed ID: 2271516
    [No Abstract]   [Full Text] [Related]  

  • 37. The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor.
    ten Cate H; Bauer KA; Levi M; Edgington TS; Sublett RD; Barzegar S; Kass BL; Rosenberg RD
    J Clin Invest; 1993 Sep; 92(3):1207-12. PubMed ID: 8376580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteolytic activation of human factors IX and X by recombinant human factor VIIa: effects of calcium, phospholipids, and tissue factor.
    Komiyama Y; Pedersen AH; Kisiel W
    Biochemistry; 1990 Oct; 29(40):9418-25. PubMed ID: 2248955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
    Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
    Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of mutations in tissue factor on the fine specificity of macromolecular substrate activation.
    Dittmar S; Ruf W; Edgington TS
    Biochem J; 1997 Feb; 321 ( Pt 3)(Pt 3):787-93. PubMed ID: 9032467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.